A conversation with Dr. Michael LaQuaglia, Chief of Pediatric Surgery at Memorial Sloan Kettering When a child is diagnosed with neuroblastoma, surgery is often one of the first things families ask about. What kind of surgery will be needed? Can the tumor be fully removed? What are the risks—and what comes next?

For families navigating a neuroblastoma diagnosis, one of the most confusing aspects is understanding the difference between stage and risk classification. Many assume that all Stage 4 neuroblastoma cases are the same, but the reality is much more complex—and personal.

Over the past six months, Shir for Life’s International Neuroblastoma Webinar Series has brought together more than 800 participants from 41 countries, creating a powerful global network of parents, doctors, researchers, and advocates. Another 800+ viewers have since watched these sessions on demand—proof of how needed and valued this resource is. Each month, we’ve tackled some of the most pressing topics in neuroblastoma, led by world-renowned experts and anchored in practi

Shir for Life hosted its 3rd Annual Parent Conference, bringing together families, doctors, researchers, and advocates for a powerful day of learning, support, and solidarity. This event was created for parents of children with neuroblastoma—to offer not just the latest in treatment updates, but also the space to connect with others who truly understand the journey.

When a child’s neuroblastoma relapses, it can feel like the ground disappears beneath you. But it’s not the end of the road. Dr. Brian H. Kushner, a leading pediatric oncologist at Memorial Sloan Kettering Cancer Center (MSK) specializing in high-risk and relapsed neuroblastoma, shares key insights for parents navigating relapse.

When Liam Brown was just a toddler, his parents thought he was catching every daycare virus. He’d come home with one illness after...